Addressing male sexual and reproductive health in the wake of COVID-19 outbreak
Top Cited Papers
Open Access
- 13 July 2020
- journal article
- review article
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 44 (2) , 223-231
Abstract
Purpose: The COVID-19 pandemic, caused by the SARS-CoV-2, represents an unprecedented challenge for healthcare. COVID-19 features a state of hyperinflammation resulting in a “cytokine storm”, which leads to severe complications, such as the development of micro-thrombosis and disseminated intravascular coagulation (DIC). Despite isolation measures, the number of affected patients is growing daily: as of June 12th, over 7.5 million cases have been confirmed worldwide, with more than 420,000 global deaths. Over 3.5 million patients have recovered from COVID-19; although this number is increasing by the day, great attention should be directed towards the possible long-term outcomes of the disease. Despite being a trivial matter for patients in intensive care units (ICUs), erectile dysfunction (ED) is a likely consequence of COVID-19 for survivors, and considering the high transmissibility of the infection and the higher contagion rates among elderly men, a worrying phenomenon for a large part of affected patients. Methods: A literature research on the possible mechanisms involved in the development of ED in COVID-19 survivors was performed. Results: Endothelial dysfunction, subclinical hypogonadism, psychological distress and impaired pulmonary hemodynamics all contribute to the potential onset of ED. Additionally, COVID-19 might exacerbate cardiovascular conditions; therefore, further increasing the risk of ED. Testicular function in COVID-19 patients requires careful investigation for the unclear association with testosterone deficiency and the possible consequences for reproductive health. Treatment with phosphodiesterase-5 (PDE5) inhibitors might be beneficial for both COVID-19 and ED. Conclusion: COVID-19 survivors might develop sexual and reproductive health issues. Andrological assessment and tailored treatments should be considered in the follow-up.Keywords
This publication has 104 references indexed in Scilit:
- Mechanisms of Severe Acute Respiratory Syndrome Coronavirus-Induced Acute Lung InjurymBio, 2013
- The Princeton III Consensus Recommendations for the Management of Erectile Dysfunction and Cardiovascular DiseaseMayo Clinic Proceedings, 2012
- Onset of effects of testosterone treatment and time span until maximum effects are achievedEuropean Journal of Endocrinology, 2011
- Functional Disability 5 Years after Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2011
- Angiotensin‐converting enzyme 2 (ACE2) expression and activity in human carotid atherosclerotic lesionsThe Journal of Pathology, 2008
- The role of hypoxia in erectile dysfunction mechanismsInternational Journal Of Impotence Research, 2007
- Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34 892 subjectsEuropean Heart Journal, 2007
- Penile Oxygen Saturation in the Flaccid and Erect Penis in Men With and Without Erectile DysfunctionJournal of Andrology, 2007
- Subclinical Erectile Dysfunction: Proposal for a Novel Taxonomic Category in Sexual MedicineThe Journal of Sexual Medicine, 2006
- Subcellular localization and regulation of type-1C and type-5 phosphodiesterasesBiochemical and Biophysical Research Communications, 2006